...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: I called E trade this morning 10/20/2020

...and explained the problem in detail...there response was "it's not our problem". This stock trades every day...it's approved by the regulators....so people can just draw down money from a stock that was spun off by RVX years ago, never has had an IPO and people are cashing out. This is egregious...RVX management should do something about this.

In my case, I will just do nothing more...I gave it my best shot to expose a serious mistake...I'll just have to let a sleeping dog lie!

Share
New Message
Please login to post a reply